Opportunity
University of Iowa Ionwave #18599
Principal Genomic Scientist Services for Molecular Tumor Board – University of Iowa Health Care
Posted
May 05, 2026
Respond By
May 21, 2026
Identifier
18599
NAICS
541690
The University of Iowa Health Care is seeking a qualified supplier to provide Principal Genomic Scientist Services in support of its Molecular Tumor Board (MTB) and Precision Medicine initiative at the Holden Comprehensive Cancer Center. - Government Buyer: - University of Iowa Health Care, Purchasing PCO 202 - Services Requested: - Principal Genomic Scientist Services - Administrative review of cases for MTB discussion - Development of molecular case report formats - Leadership of MTB meetings - Interpretation of molecular findings for clinical decision-making and clinical trial matching - Ad hoc consultation and educational support for clinical teams - Participation in IMTB steering meetings with 24-hour response availability - Ensuring compliance with best practices and regulatory standards - Requirements: - Demonstrated expertise in molecular genomics and experience leading a Molecular Tumor Board - Submission of detailed proposals, CVs, financial statements, and references - Compliance with federal regulations and University procedures - Period of Performance: - Initial one-year contract with up to four one-year extension options (potential total of five years) - Locations: - University of Iowa Health Care medical centers and clinics in Iowa City and North Liberty, Iowa - No specific OEMs or commercial vendors are named in the solicitation
Description
The University of Iowa is soliciting qualifications for Principal Genomic Scientist Services to support the IOWA Molecular Program and the Molecular Tumor Board (MTB) as part of the Precision Medicine initiative for the Holden Comprehensive Cancer Center. The scope includes administrative review of cases, development of molecular case report formats, leading MTB meetings, interpreting molecular findings, and providing consultative expertise. The contract will be for one year with possible extensions up to five years. The University seeks a reputable supplier with demonstrated ability in molecular genomics consultation and advisory services.